Lobbying

Posit Science's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $140K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Posit Science

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$140K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Posit Science lobbying by quarter
Posit Science lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$40K1
Q2 2023$40K1
Q3 2023$40K1
Q4 2023$40K1
Q1 2024$40K1
Q2 2024$40K1
Q3 2024$40K1
Q4 2024$40K1
Q1 2025$40K1
Q2 2025$40K1
Q3 2025$40K1
Q4 2025$40K1
Q1 2026$50K1
Q2 2026$50K1
Q3 2026$00

By issue

  • Health issues$206.7K · 15 reports
  • Medicare and Medicaid$206.7K · 15 reports
  • Defense$126.7K · 10 reports
  • Veterans$80K · 7 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Centers For Medicare and Medicaid Services (CMS)12 reports
  • Veterans Affairs, Dept of (VA)7 reports
  • Health & Human Services, Dept of (HHS)5 reports

Firms it paid

Firm
Hooper, Lundy & Bookman, P.C.$620K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/30for Q3 2025Hooper, Lundy & Bookman, P.C.$40K
07/19for Q2Hooper, Lundy & Bookman, P.C.$50K
04/20for Q1Hooper, Lundy & Bookman, P.C.$50K
01/16for Q4 2025Hooper, Lundy & Bookman, P.C.$40K
25/10/19for Q3 2025Hooper, Lundy & Bookman, P.C.$40K
25/07/18for Q2 2025Hooper, Lundy & Bookman, P.C.$40K
25/04/18for Q1 2025Hooper, Lundy & Bookman, P.C.$40K
25/01/17for Q4 2024Hooper, Lundy & Bookman, P.C.$40K
24/10/17for Q3 2024Hooper, Lundy & Bookman, P.C.$40K
24/07/18for Q2 2024Hooper, Lundy & Bookman, P.C.$40K
24/04/19for Q1 2024Hooper, Lundy & Bookman, P.C.$40K
24/01/18for Q4 2023Hooper, Lundy & Bookman, P.C.$40K
23/10/19for Q3 2023Hooper, Lundy & Bookman, P.C.$40K
23/07/20for Q2 2023Hooper, Lundy & Bookman, P.C.$40K
23/04/20for Q1 2023Hooper, Lundy & Bookman, P.C.$40K
23/01/20for Q4 2022Hooper, Lundy & Bookman, P.C.$40K